Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The Role of Local Therapy in Multi-focal Epithelioid Haemangioendothelioma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association of CD31 and p53 With Survival of Ovarian Cancer Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The Influence of Cyst Emptying, Lymph Node Resection and Chemotherapy on Survival in Stage IA and IC1 Epithelial Ovarian Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Diabetes i familien – familien og diabetes

    Publikation: Bidrag til tidsskriftBidrag til avis - Kommentar/debatFormidling

  2. Diabetespatienter er afhængige af et løft af det nære sundhedsvæsen

    Publikation: AndetUdgivelser på nettet - Net-publikationFormidling

  3. Forord

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiFormidling

  4. Kun gode relationer kan nedbryde ’Sundhedsvæsnets Bermudatrekant’

    Publikation: Bidrag til tidsskriftBidrag til avis - Kommentar/debatFormidling

  • Henning Grønbaek
  • Vasilios Tanos
  • Dror Meirow
  • Tamar Peretz
  • Itamar Raz
  • Allan Flyvbjerg
Vis graf over relationer

BACKGROUND: Recently an association between increased serum insulin-like growth factor I (IGF-I) levels and the development of breast cancer was demonstrated. Tamoxifen used in the postoperative treatment of breast cancer patients may exert significant effects on the IGF-I system.

MATERIALS AND METHODS: To examine the effect of Tamoxifen treatment (20 mg/day) on changes in the IGF-I axis in 11 breast cancer patients before and after 4 months of Tamoxifen treatment and compared to 8 healthy subjects. IGF-I, IGF-II, IGFBP-1, IGFBP-2, IGFBP-3 and IGFBP-6 were examined by specific assays. IGFBPs were examined by Western ligand blotting and IGFBP-3 proteolytic activity by specific protease assay.

RESULTS: Serum IGF-I was decreased before (63%) and increased during Tamoxifen treatment (60%). Total IGFBP-3 levels measured by IRMA were unchanged, however, intact IGFBP-3 measured by WLB was decreased (58%) before and increased (67%) during Tamoxifen treatment. IGFBP-3 proteolysis was increased before and reduced during treatment. IGFBP-4 and IGFBP-6 were decreased before and increased during Tamoxifen treatment.

CONCLUSION: Significant changes in the IGF system were demonstrated before and during Tamoxifen treatment and may in part be involved in the effects of Tamoxifen treatment in breast cancer patients.

OriginalsprogEngelsk
TidsskriftAnticancer Research
Vol/bind23
Udgave nummer3C
Sider (fra-til)2815-20
Antal sider6
ISSN0250-7005
StatusUdgivet - 21 aug. 2003
Eksternt udgivetJa

ID: 51977015